MENU
+Compare
DXR
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$10.14
Change
+$0.14 (+1.40%)
Capitalization
42.31M

DXR Daxor Corp Forecast, Technical & Fundamental Analysis

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement... Show more

DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DXR with price predictions
Jul 25, 2025

DXR sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for DXR moved above the 200-day moving average on July 07, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 23, 2025. You may want to consider a long position or call options on DXR as a result. In of 121 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DXR just turned positive on July 25, 2025. Looking at past instances where DXR's MACD turned positive, the stock continued to rise in of 58 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DXR advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 175 cases where DXR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DXR moved out of overbought territory on June 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

DXR broke above its upper Bollinger Band on July 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DXR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.244) is normal, around the industry mean (24.533). P/E Ratio (62.872) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (33.003) is also within normal values, averaging (43.112).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

DXR paid dividends on January 12, 2018

Daxor Corp DXR Stock Dividends
А dividend of $0.03 per share was paid with a record date of January 12, 2018, and an ex-dividend date of January 05, 2018. Read more...
A.I. Advisor
published General Information

General Information

a provider of original medical equipment for medical personnel

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
109 Meco Lane
Phone
+1 212 330-8500
Employees
12
Web
https://www.daxor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APH105.020.56
+0.54%
Amphenol Corp
MSC4.57N/A
N/A
Studio City International Holdings Limited
AMBI4.65N/A
N/A
Ambipar Emergency Response
VFC12.67-0.01
-0.08%
VF Corp
RPID4.08-0.26
-5.99%
Rapid Micro Biosystems

DXR and Stocks

Correlation & Price change

A.I.dvisor tells us that DXR and IART have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DXR and IART's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXR
1D Price
Change %
DXR100%
+1.44%
IART - DXR
33%
Poorly correlated
+3.15%
BWAY - DXR
27%
Poorly correlated
-0.93%
NOTV - DXR
24%
Poorly correlated
-5.93%
QIPT - DXR
23%
Poorly correlated
+1.83%
COO - DXR
20%
Poorly correlated
+1.07%
More